Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IDEAYA Biosciences (IDYA) Cash from Financing Activities: 2017-2024

Historic Cash from Financing Activities for IDEAYA Biosciences (IDYA) over the last 8 years, with Dec 2024 value amounting to $677.6 million.

  • IDEAYA Biosciences' Cash from Financing Activities fell 99.89% to $301,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $30.4 million, marking a year-over-year decrease of 96.27%. This contributed to the annual value of $677.6 million for FY2024, which is 86.80% up from last year.
  • IDEAYA Biosciences' Cash from Financing Activities amounted to $677.6 million in FY2024, which was up 86.80% from $362.7 million recorded in FY2023.
  • IDEAYA Biosciences' Cash from Financing Activities' 5-year high stood at $677.6 million during FY2024, with a 5-year trough of $97.2 million in FY2022.
  • In the last 3 years, IDEAYA Biosciences' Cash from Financing Activities had a median value of $362.7 million in 2023 and averaged $379.1 million.
  • Its Cash from Financing Activities has fluctuated over the past 5 years, first crashed by 33.20% in 2022, then spiked by 273.30% in 2023.
  • IDEAYA Biosciences' Cash from Financing Activities (Yearly) stood at $128.8 million in 2020, then increased by 12.97% to $145.5 million in 2021, then tumbled by 33.20% to $97.2 million in 2022, then spiked by 273.30% to $362.7 million in 2023, then skyrocketed by 86.80% to $677.6 million in 2024.